Data / Form D filings / AgelessRx, Inc.
AgelessRx, Inc.: Form D filing
AgelessRx, Inc., a biotechnology company in Ann Arbor, MI, filed a Form D with the SEC in 2026. The latest, on March 17, 2026, reports $5.5 million sold of an offering with no set size to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2370 E STADIUM BLVD #2049, Ann Arbor, MI, 48104
- Phone
- (650) 503-9990
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2109810
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | New notice | Indefinite | $5,473,242 | 32 | Jan 12, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Michael Pejovich | Executive Officer | Director of Finance of the Issuer |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AgelessRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.